Seeking Alpha

JMP (Outperform) boosts its price target on Acadia Pharmaceuticals (ACAD +3.2%) to $27 from $16....

JMP (Outperform) boosts its price target on Acadia Pharmaceuticals (ACAD +3.2%) to $27 from $16. SA contributor PTSD Trader recently said pimavanserin is the "silver lining in the company's playbook."
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)